Neuromodulation trials

Assessment of OSA in Latin American and Response to Neuromod Therapy

RecruitingNCT06762873Phase: EARLY_PHASE1Started 2024-11-21

Summary

The purpose of this study is to characterize the upper airway of Latin American subjects who have been diagnosed with moderate/severe obstructive sleep apnea (OSA) and assess response to a neuromodula

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
None

Locations

Sanatorio AmericanoAsunción, Paraguay

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT06762873